MID-VOLUME · SEX-BALANCED
baricitinib Side Effects
baricitinib (also sold as Olumiant) sits MID-VOLUME #328 of 524 by FAERS report count. Lead signal: SEX-BALANCED - 67% of sex-coded reports are female (5,641 F / 2,741 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 9,259
- FAERS reports
FDA Adverse Event Reporting System extract for baricitinib. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
baricitinib reporting skew - 67% of sex-coded reports are female (5,641 F / 2,741 M). Volume band MID-VOLUME #328 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for baricitinib (Olumiant) (9,259 reports). Signature SEX-BALANCED. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2012–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
COVID-19 leads 439 of 9,259 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (2,625 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (866 reports, 9.4%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 229 |
| COVID-19 | 80 |
| RESPIRATORY FAILURE | 48 |
| CARDIAC ARREST | 45 |
| COVID-19 PNEUMONIA | 41 |
| SEPSIS | 41 |
| PULMONARY EMBOLISM | 39 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 34 |
| PNEUMONIA | 33 |
| SEPTIC SHOCK | 28 |
| ACUTE KIDNEY INJURY | 27 |
| ACUTE RESPIRATORY DISTRESS SYNDROME | 25 |
| CARDIO-RESPIRATORY ARREST | 24 |
| CARDIAC FAILURE | 22 |
| ACUTE RESPIRATORY FAILURE | 21 |
| ISCHAEMIC STROKE | 21 |
| BRONCHOPULMONARY ASPERGILLOSIS | 20 |
| DYSPNOEA | 20 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (3,011, 32.5% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| COVID-19 | 227 |
| PNEUMONIA | 185 |
| RHEUMATOID ARTHRITIS | 181 |
| PULMONARY EMBOLISM | 154 |
| DEEP VEIN THROMBOSIS | 109 |
| DYSPNOEA | 99 |
| HERPES ZOSTER | 88 |
| PYREXIA | 83 |
| ARTHRALGIA | 77 |
| URINARY TRACT INFECTION | 75 |
| ARTHRITIS | 73 |
| ACUTE KIDNEY INJURY | 72 |
| FALL | 71 |
| RESPIRATORY FAILURE | 70 |
| VOMITING | 69 |
| COVID-19 PNEUMONIA | 65 |
| SEPSIS | 63 |
| ANAEMIA | 62 |
How to read baricitinib FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 9,259 voluntary reports linked to baricitinib (Olumiant), 2012-2025. Death is listed on 866 (9.4%). Hospitalization appears on 3,011 (32.5%). Top co-reported indication: Rheumatoid Arthritis.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 67% of sex-coded reports are female (5,641 F / 2,741 M).
Read with baricitinib
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 9,140 FAERS cases (Δ 119 lighter vs baricitinib); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,400 FAERS cases (Δ 141 heavier vs baricitinib); DEATH-RARE · HOSP-LIGHT · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,102 FAERS cases (Δ 157 lighter vs baricitinib); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,450 FAERS cases (Δ 191 heavier vs baricitinib); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 52.8 pp vs baricitinib's DEATH-HEAVY): CASELOAD · HOSP-MID.
baricitinib stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.